![Israel Makov, outgoing president and CEO of Teva Pharmaceutical Industries, Ltd. takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock Israel Makov, outgoing president and CEO of Teva Pharmaceutical Industries, Ltd. takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock](https://c8.alamy.com/comp/TYHXYG/israel-makov-outgoing-president-and-ceo-of-teva-pharmaceutical-industries-ltd-takes-part-in-the-opening-bell-ceremonies-at-the-nasdaq-in-new-york-on-february-21-2007-upi-photolaura-cavanaugh-TYHXYG.jpg)
Israel Makov, outgoing president and CEO of Teva Pharmaceutical Industries, Ltd. takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock
New York Stock Exchange - NEW YORK, NY - MAY 30: Teva Pharmaceutical Industries' Chairman of the Board of Directors, Dr. Phillip Frost and President and CEO Dr. Jeremy M. Levin, joined
![Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1644418506/Teva.jpg/Teva.jpg?VersionId=rO8YFG.CL6Gv3CRoUHLVIzxA43jocNbb)